Clinical Trials Browser

Phase NA × Hearing Loss × 90 days × Clear all

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

NCT07420751 2026-04-28

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Phase NA Active not recruiting

18 enrolled

CNS

Neurofibromatosis 2, Hearing Loss

NCT06036407 2026-04-14

HEAR

Phase NA Completed

476 enrolled

Ototoxicity, Neoplasms, Hearing Loss

Clinical Trials

TIMELY REHAB

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

HEAR